Pharmaceutical Segment for the Second Half

Increase in sales and operating income, expecting strong gain

Breakdown

 • Increase sales of SYCREST, Bilanoa and generic drugs

 • Cost reduction

 • Sales expansion of KM Biologics
Increase in sales of Flu vaccine, seasonality

Concerns

 • Harsh NHI drug price reduction, may be conducted every year

 • Mirtazapine, generic version of REFLEX, will become available in December